Pfizer Moves to Dismiss Lawsuit From COVID-19 Vaccine Trial, Citing ‘Prototype’ Agreement

5Mind. The Meme Platform
The Epoch Times Header

Pfizer has asked a U.S. court to throw out a lawsuit from a whistleblower who revealed problems at sites that tested Pfizer’s COVID-19 vaccine.

Brook Jackson, the whistleblower, alleged in a suit that was unsealed in February that Pfizer and associated parties violated clinical trial regulations and federal laws, including the False Claims Act.

In its motion to dismiss, Pfizer says the regulations don’t apply to its vaccine contract with the U.S. Department of Defense because the agreement was executed under the department’s Other Transaction Authority (OTA), which gives contract holders the ability to skirt many rules and laws that typically apply to contracts.

That means that Jackson’s claim that Pfizer must still comply with the Federal Acquisition Regulations “is simply wrong,” Pfizer said.

Warner Mendenhall, a lawyer who is working on Jackson’s case, said in a recent interview that Pfizer has “clearly not followed federal procurement laws.”

“And now they’re saying, ‘of course we didn’t follow federal procurement laws, we didn’t have to—this was just for a prototype,’” he added.

Mendenhall, who declined an interview request, said lawyers for Jackson are working on figuring out legal ways to counter Pfizer’s argument.

“We may lose on this issue because their contract imposes … none of the normal checks and balances on quality control and consumer protection that we fought for decades in this country,” he said.

The contract in question was outlined in a base agreement and a statement of work for the agreement, which was signed in the summer of 2020.

The government agreed to pay up to $1.9 billion for 100 million doses of the COVID-19 vaccine pending U.S. regulatory clearance. That included the manufacturing of the vaccine on top of researching and developing it.

The contract was granted under the “prototype” provision, which falls under the OTA. The rules for prototypes state that just one of four conditions must be satisfied. The condition that was satisfied in the Pfizer contract was the involvement of a “nontraditional defense contractor.”

By Zachary Stieber

Read Full Article on TheEpochTimes.com

Contact Your Elected Officials
The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Mr. CIA COVID ‘Whistleblower’ Goes to Washington

The real question: How could an active CIA agent “blow the whistle” on the agency he works for all of his own volition?

South Korea Will Remain A Key Part Of The US’ Chinese Containment Plans

Trump-Xi optimism dimmed after a quieter U.S.-South Korea defense meeting in Washington raised doubts about easing Sino-US tensions.

When Institutional Language Becomes Policy

Frequency, tone, repetition, thematic emphasis, and omission can now be studied across large bodies of text. Patterns once dismissed as anecdotal can be analyzed and tested.

America In Crisis: The Clueless Masses Need To Wake Up!

There seems to be a growing number of Americans who believe this country is some horrible, oppressive nightmare.

Breaching constitutional limits

Bill 1957 would restructure Pennsylvania’s constitution and give abortion and a wide range of “personal reproductive decisions” legal protection.

US Border Patrol ​Chief Michael Banks Resigns

U.S. Border Patrol ​Chief Michael Banks resigned from his position confirmed by CBP Commissioner Rodney Scott.

Pill Prevents COVID-19 After Exposure to Infected People: Study

A pill called ensitrelvir prevented COVID-19 in people who were exposed to infected individuals, according to a new study.

Senate Confirms Kevin Warsh as New Fed Chair

Kevin Warsh will officially become the new head of the Federal Reserve. The Senate voted 54–45 to confirm Warsh’s four-year term as the 17th Fed chair.

‘Obvious Dangers’: Gabbard Probing US Funding to International Biolaboratories

U.S. DNI Tulsi Gabbard and other intelligence officials are investigating U.S. funding to overseas laboratories handling biological research.

Trump Heading to China for High-Stakes Summit With Xi

President Trump is set to depart Washington for China, where he will meet with Chinese leader Xi Jinping for a high-stakes summit.

Tech, Business Leaders Set to Accompany Trump on China Trip

President Trump is bringing a delegation of business executives when he travels to China for a summit with Chinese Communist Party leader Xi Jinping.

Trump Nominates FEMA Lead Fired From Role a Year Ago

The WH released a list of nominees for various positions across the federal government, including former Navy SEAL Cameron Hamilton to take over aa lead.

What to Know About Trump’s Presidential Fitness Test Award Revival

In the coming academic year, old-fashioned calisthenics, timed runs, and the spirit of competition could return to many public schools.
spot_img

Related Articles

Popular Categories

MAGA Business Central